Ragavan, Narasimhan, Hewitt, Rebecca, Hindley, Andrew C., Nicholson, C. M., Matanhelia, Shyam S. and Martin, Francis L ORCID: 0000-0001-8562-4944
(2006)
CYP1B1 expression is higher in the peripheral zone compared to the transition zone : a difference underlying zonal susceptibility to prostate adenocarcinoma?
Prostate Cancer and Prostatic Diseases, 9
(3).
p. 316.
ISSN 1365-7852
Ragavan, Narasimhan, Hewitt, Rebecca, Hindley, Andrew C., Nicholson, C. M., Matanhelia, Shyam S. and Martin, Francis L ORCID: 0000-0001-8562-4944
(2006)
Expression of hormone-/carcinogen-metabolising enzymes in the prostate : clues into peripheral-zone susceptability?
European Urology Supplements, 5
(2).
p. 165.
ISSN 1569-9056
Martin, Francis L ORCID: 0000-0001-8562-4944, Ragavan, N., Hewitt, Rebecca, Hindley, Andrew C., Nicholson, C. M. and Matanhelia, Shyam S.
(2005)
CYP1B1 expression and peripheral-zone susceptibility to prostate adenocarcinoma : comparisons with other carcinogen/hormone-metabolising enzymes.
Proceedings of the American Association for Cancer Research, 46
(162).
p. 316.
ISSN 0569-2261
Ragavan, N., Hewitt, R., Cooper, Leanne J., Ashton, K. M., Hindley, A. C., Nicholson, C. M., Fullwood, Nigel J., Matanhelia, S. S. and Martin, Francis L ORCID: 0000-0001-8562-4944
(2004)
CYP1B1 expression in prostate is higher in peripheral compared to transition zone.
Cancer Letters, 215
(1).
pp. 69-78.
ISSN 0304-3835
Ragavan, Narasimhan, Hewitt, Rebecca, Hindley, Andrew C., Nicholson, C. M., Matanhelia, Shyam S. and Martin, Francis L ORCID: 0000-0001-8562-4944
(2004)
Inter-and intra-individual variations in prostate CYP1B1 expression suggest a role in peripheral-zone susceptibility to adenocarcinoma.
Mutagenesis, 19
(6).
p. 503.
ISSN 0267-8357
Martin, Francis L ORCID: 0000-0001-8562-4944, Ragavan, N., Hewitt, R., Nicholson, C. M., Matanhelia, S. S., Hindley, A. C. and McMillan, T. J.
(2004)
Pre-existing levels of CYP1B1 expression in human prostate tissues modulated by 17 b-oestradiol in the presence of bezoapyrene.
In: American Association for Cancer Research 45 Conference.